Laleh Majlessi

8PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safetyComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Central nervous systemMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 30, 2025
Intratumoral delivery of FLT3L with CXCR3/CCR5 ligands promotes XCR1+ cDC1 infiltration and activates anti-tumor immunity.

Louise Gorline, Fillipe Luiz Rosa do Carmo, Pierre Bourdely

|Sep 07, 2023
Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.

Laëtitia Douguet, Ingrid Fert, Jodie Lopez

|Dec 20, 2021
[An anti-Covid-19 lentiviral vaccine candidate that can be administered by the nasal route].

Laleh Majlessi, Pierre Charneau

|Oct 14, 2021
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.

Min-Wen Ku, Pierre Authié, Maryline Bourgine

|Jun 11, 2021
Lentiviral vector induces high-quality memory T cells via dendritic cells transduction.

Min Wen Ku, Pierre Authié, Fabien Nevo

Pageof 2